The MARS demonstrated fair psychometric characteristics in assessing adherence in patients with schizophrenia in this cohort. The scale may be useful in the dimensional assessment of medication adherence for schizophrenia in sub-Saharan African settings.
No takes yet. Share an insight, caveat, or question.
Owie et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: